ID24819A - TURUNAN ASAM α-HIDROSIKARBOKSILAT TERSUBSTITUSI SECARA HETEROSIKLIK, PEMBUATAN DAN PENGGUNAANNYA SEBAGAI ANTAGONIS RESEPTOR ENDOTELIN - Google Patents
TURUNAN ASAM α-HIDROSIKARBOKSILAT TERSUBSTITUSI SECARA HETEROSIKLIK, PEMBUATAN DAN PENGGUNAANNYA SEBAGAI ANTAGONIS RESEPTOR ENDOTELINInfo
- Publication number
- ID24819A ID24819A IDW20000882A ID20000882A ID24819A ID 24819 A ID24819 A ID 24819A ID W20000882 A IDW20000882 A ID W20000882A ID 20000882 A ID20000882 A ID 20000882A ID 24819 A ID24819 A ID 24819A
- Authority
- ID
- Indonesia
- Prior art keywords
- herthiciclic
- endoteline
- substitution
- making
- receptor antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
- C07D275/02—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
- C07D275/03—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/12—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/36—One oxygen atom
- C07D263/38—One oxygen atom attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/34—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19750529A DE19750529A1 (de) | 1997-11-14 | 1997-11-14 | Neue heterocyclisch substituierte alpha-Hydroxycarbonsäurederivate, ihre Herstellung und Verwendung als Endothelinrezeptorantagonisten |
| PCT/EP1998/007026 WO1999025701A1 (de) | 1997-11-14 | 1998-11-04 | NEUE HETEROCYCLISCH SUBSTITUIERTE α-HYDROXYCARBONSÄUREDERIVATE, IHRE HERSTELLUNG UND VERWENDUNG ALS ENDOTHELINREZEPTORANTAGONISTEN |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID24819A true ID24819A (id) | 2000-08-24 |
Family
ID=7848772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW20000882A ID24819A (id) | 1997-11-14 | 1998-11-04 | TURUNAN ASAM α-HIDROSIKARBOKSILAT TERSUBSTITUSI SECARA HETEROSIKLIK, PEMBUATAN DAN PENGGUNAANNYA SEBAGAI ANTAGONIS RESEPTOR ENDOTELIN |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6358983B1 (es) |
| EP (1) | EP1037883A1 (es) |
| JP (1) | JP2001523671A (es) |
| KR (1) | KR20010032083A (es) |
| CN (1) | CN1278805A (es) |
| AR (1) | AR017581A1 (es) |
| AU (1) | AU752165B2 (es) |
| BG (1) | BG104400A (es) |
| BR (1) | BR9814157A (es) |
| CA (1) | CA2308746A1 (es) |
| CO (1) | CO4990973A1 (es) |
| DE (1) | DE19750529A1 (es) |
| HR (1) | HRP980591A2 (es) |
| HU (1) | HUP0004341A3 (es) |
| ID (1) | ID24819A (es) |
| IL (1) | IL135461A0 (es) |
| NO (1) | NO20002154L (es) |
| NZ (1) | NZ504289A (es) |
| PL (1) | PL340756A1 (es) |
| SK (1) | SK4932000A3 (es) |
| TR (1) | TR200001365T2 (es) |
| WO (1) | WO1999025701A1 (es) |
| ZA (1) | ZA9810425B (es) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE493973T1 (de) | 2004-06-04 | 2011-01-15 | Teva Pharma | Irbesartan enthaltende pharmazeutische zusammensetzung |
| MY146830A (en) * | 2005-02-11 | 2012-09-28 | Novartis Ag | Combination of organic compounds |
| US7790770B2 (en) | 2005-11-23 | 2010-09-07 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19533023B4 (de) * | 1994-10-14 | 2007-05-16 | Basf Ag | Neue Carbonsäurederivate, ihre Herstellung und Verwendung |
-
1997
- 1997-11-14 DE DE19750529A patent/DE19750529A1/de not_active Withdrawn
-
1998
- 1998-11-04 PL PL98340756A patent/PL340756A1/xx not_active Application Discontinuation
- 1998-11-04 SK SK493-2000A patent/SK4932000A3/sk unknown
- 1998-11-04 JP JP2000521084A patent/JP2001523671A/ja active Pending
- 1998-11-04 ID IDW20000882A patent/ID24819A/id unknown
- 1998-11-04 HU HU0004341A patent/HUP0004341A3/hu unknown
- 1998-11-04 CN CN98811085A patent/CN1278805A/zh active Pending
- 1998-11-04 IL IL13546198A patent/IL135461A0/xx unknown
- 1998-11-04 BR BR9814157-0A patent/BR9814157A/pt not_active IP Right Cessation
- 1998-11-04 TR TR2000/01365T patent/TR200001365T2/xx unknown
- 1998-11-04 CA CA002308746A patent/CA2308746A1/en not_active Abandoned
- 1998-11-04 EP EP98958900A patent/EP1037883A1/de not_active Withdrawn
- 1998-11-04 US US09/530,382 patent/US6358983B1/en not_active Expired - Fee Related
- 1998-11-04 WO PCT/EP1998/007026 patent/WO1999025701A1/de not_active Application Discontinuation
- 1998-11-04 AU AU14878/99A patent/AU752165B2/en not_active Ceased
- 1998-11-04 NZ NZ504289A patent/NZ504289A/en unknown
- 1998-11-04 KR KR1020007005207A patent/KR20010032083A/ko not_active Application Discontinuation
- 1998-11-09 AR ARP980105651A patent/AR017581A1/es not_active Application Discontinuation
- 1998-11-13 CO CO98067231A patent/CO4990973A1/es unknown
- 1998-11-13 ZA ZA9810425A patent/ZA9810425B/xx unknown
- 1998-11-13 HR HR19750529.5A patent/HRP980591A2/hr not_active Application Discontinuation
-
2000
- 2000-04-27 NO NO20002154A patent/NO20002154L/no not_active Application Discontinuation
- 2000-05-04 BG BG104400A patent/BG104400A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA2308746A1 (en) | 1999-05-27 |
| CO4990973A1 (es) | 2000-12-26 |
| WO1999025701A1 (de) | 1999-05-27 |
| HRP980591A2 (en) | 1999-08-31 |
| ZA9810425B (en) | 2000-05-15 |
| SK4932000A3 (en) | 2001-02-12 |
| NO20002154L (no) | 2000-05-12 |
| AR017581A1 (es) | 2001-09-12 |
| CN1278805A (zh) | 2001-01-03 |
| BG104400A (en) | 2001-01-31 |
| NO20002154D0 (no) | 2000-04-27 |
| KR20010032083A (ko) | 2001-04-16 |
| BR9814157A (pt) | 2000-10-03 |
| IL135461A0 (en) | 2001-05-20 |
| DE19750529A1 (de) | 1999-05-20 |
| HUP0004341A1 (hu) | 2001-10-28 |
| JP2001523671A (ja) | 2001-11-27 |
| PL340756A1 (en) | 2001-02-26 |
| HUP0004341A3 (en) | 2001-12-28 |
| TR200001365T2 (tr) | 2000-09-21 |
| EP1037883A1 (de) | 2000-09-27 |
| US6358983B1 (en) | 2002-03-19 |
| NZ504289A (en) | 2002-03-01 |
| AU1487899A (en) | 1999-06-07 |
| AU752165B2 (en) | 2002-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69812096D1 (de) | Neuropeptid y rezeptorantagonisten | |
| TR199801594A3 (tr) | CCR-3 reseptör antagonistleri. | |
| ID19253A (id) | Bahan antagonis reseptor vitronektin, pembuatannya dan penggunaannya | |
| DK1009732T3 (da) | 1-Amino-alkylcyclohexan NMDA receptor antagonister | |
| DE69734833D1 (de) | Vitronektin rezeptor antagonisten | |
| ID26774A (id) | Senyawa benzimidazol, pembuatan dan penggunaannya sebagai komposisi farmasi | |
| ID25528A (id) | Karboksamidotiazol tersubstitusi, pembuatannya dan komposisi farmasi yang mengandungnya | |
| ID16742A (id) | Antagonis reseptor endotelin | |
| ATE280157T1 (de) | 4-aroyl-piperidin-ccr-3 rezeptor antagonisten iii | |
| AU8689798A (en) | Integrin receptor antagonists | |
| ID22916A (id) | Turunan-turunan ergolin dan penggunaannya sebagai antagonis reseptor somatostatin | |
| ID24726A (id) | Antagonis-antagonis reseptor trombin | |
| ID26223A (id) | Antagonis reseptor vitronektin | |
| ID24162A (id) | Antagonis-antagonis reseptor vitronektin | |
| ID17266A (id) | Antagonis antagonis reseptor d4 dopamin benzoksazinon | |
| ID22838A (id) | Oksazolidina sebagai antagonis 5-ht2a | |
| ID24633A (id) | Turunan tetrahidropirimidinon 3-tersubstitusi, pembuatan dan penggunaannya | |
| ID24468A (id) | 2-asilaminopropanamina sebagai antagonis reseptor tachykinin | |
| ID27845A (id) | Turunan tetrahidrokuilina sebagai antagonis glisilina | |
| TR199501389A2 (tr) | Adesyon reseptörü antagonistleri (karsitlari). | |
| AU1296899A (en) | Phenyl-alkyl-imidazoles as h3 receptor antagonists | |
| ID26234A (id) | Turunan-turunan asam karboksilat heterosiklik, pembuatan dan penggunaannya sebagai antagonis-antagonis reseptor endotelen | |
| ID24346A (id) | Turunan asam karboksilat betha -amino dan betha -azido baru, pembuatan dan penggunaannya sebagai antagonis reseptor andotelin | |
| ID24306A (id) | Turunan asam kuinolin-2 karboksilat dan penggunaannya sebagai antagonis asam amino eksitatori | |
| ID24819A (id) | TURUNAN ASAM α-HIDROSIKARBOKSILAT TERSUBSTITUSI SECARA HETEROSIKLIK, PEMBUATAN DAN PENGGUNAANNYA SEBAGAI ANTAGONIS RESEPTOR ENDOTELIN |